|
Jiangsu Hengrui Pharmaceuticals Co., Ltd
|
Cisatracurium Besylate is a bisbenzyltetrahydroisoquinolinium that has effect as a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively inanesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation duringsurgery or mechanical ventilation. It shows intermediate duration of action. Cisatracurium is one of the ten isomers of the parent molecule, atracurium. Moreover, cisatracurium represents approximately 15% of the atracurium mixture.
For this API product, we have got Chinese local GMP certificate, and US-DMF of this API is available. EDMF is submitted in schedule. It was launched into Asian and South American market.
For this Finished Dose Form, Cisatracurium Besylate for Injection, files have been submitted to multiple authorities of various countries for approval. It is the one of key products in our company’s anaesthetic products’ line. It was submitted to US FDA for approval in 2012 and expected approval and launch date is 2017.
|
Send Inquiry
|
|
Hangzhou Verychem Science And Technology Co.Ltd
|
Injection 10mg/5mL
Pharmaceutical intermsdiates Assay: 99%min
Hangzhou Verychem Science And Technology Co. Ltd. was set up in year 2004, it’s a young but fast growing
company. In the twelve years history, it invested two pharmaceutical raw material production plants, one
researching company, and several individual intermediates projects with cooperated production base. It is
devoted in exporting its pharmaceutical raw materials and importing APIs & finished formulation products into
China Market.
We accept chemical custom synthesis and keep business confidence. Our key technologies include chiral synthesis,
enzymatic resolution, fast exothermic reaction, Grignard reaction, high vacuum distillation. We make careful
study on impurities which help us give out better quality.
We are one of the largest suppliers on Entecavir intermediates, we have own manufactory and best competitive quantity price and quality .
|
Send Inquiry
|
Pharma Sources Insight JUNE2022
